Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002170008 | SCV002335007 | benign | not provided | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002551337 | SCV003759144 | uncertain significance | Inborn genetic diseases | 2022-07-08 | criteria provided, single submitter | clinical testing | The c.3629G>A (p.R1210H) alteration is located in exon 22 (coding exon 22) of the NOTCH3 gene. This alteration results from a G to A substitution at nucleotide position 3629, causing the arginine (R) at amino acid position 1210 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
ARUP Laboratories, |
RCV002170008 | SCV004562193 | likely benign | not provided | 2023-03-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002170008 | SCV005315454 | benign | not provided | criteria provided, single submitter | not provided | ||
John Welsh Cardiovascular Diagnostic Laboratory, |
RCV002285182 | SCV002575047 | uncertain significance | Pulmonary arterial hypertension | 2022-09-26 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004538782 | SCV004747423 | likely benign | NOTCH3-related disorder | 2022-11-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |